The research-use-only MRDTectTM NPM1 and FLT3 ITD panel is Pillar’s first product to support localized NGS-based MRD testing, uniting ultrasensitive NPM1 and FLT3-ITD detection in a single-tube, DNA-based workflow that laboratories can run in-house NATICK, Mass. — October 22, 2026 — Pillar Biosciences, Inc., a leader in oncology-focused next-generation sequencing (NGS) solutions, today announced the launch […]
Discovery
- searchSearch
- storefrontProducts
- hubMCP Server
- monitoringAnalytics
- query_statsSearch Terms
- workspace_premiumScore
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules